Ignite Creation Date:
2025-12-24 @ 3:23 PM
Ignite Modification Date:
2026-02-24 @ 12:14 AM
Study NCT ID:
NCT02967692
Status:
TERMINATED
Last Update Posted:
2025-09-18
First Post:
2016-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-21
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-16
First Submit QC Date:
None
Study First Post Date:
2016-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-06-26
Results First Submit QC Date:
None
Results First Post Date:
2023-07-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-07-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-09-01
Last Update Post Date:
2025-09-18
Last Update Post Date Type:
ESTIMATED